NEWS

Thursday, November 2, 2023

Thomas London has joined the board of Oslo Cancer Cluster Incubator.

Thursday, October 19, 2023

How can manufacturing of T cell therapies be improved?

Wednesday, October 18, 2023

New data shows 27% improved survival in the NIPU trial.

Friday, October 6, 2023

Her er de viktigste sakene i Statsbudsjettet 2024 for Oslo Cancer Clusters medlemmer.

Thursday, September 28, 2023

SurViva is a Norwegian consultancy providing quality guidance for life science companies.

Wednesday, September 6, 2023

New Norwegian research in polygenic risk score

Wednesday, August 23, 2023

What is the government's ambition for the health industry?

Monday, August 21, 2023

Smaller patient groups and targeted treatments are the future…

Tuesday, August 15, 2023

How will Norway implement the Mission on Cancer?